Connect with us

Health

Anti-infective therapy for infections caused by drug-resistant gram-negative pathogens now in Phase I study – Outbreak News Today – Outbreak News Today

By NewsDesk  @infectiousdiseasenews Biopharmaceutical company, Qpex Biopharma, announced this week the initiation of a Phase…

Published

on

Article feature image

By NewsDesk  @infectiousdiseasenews
Biopharmaceutical company, Qpex Biopharma, announced this week the initiation of a Phase 1 study of QPX9003, a next generation intravenous (IV)-administered synthetic polymyxin for infections caused by drug-resistant…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
New insights into participation of underrepresented communities in Alzheimer’s clinical trials – News-Medical.Net
Article feature image
Drug combination could make curative surgery possible for some liver cancer patients – News-Medical.net